Profound Medical Corp. Profound Medical Corp.

Profound Medical Corp.

PROF

Rank in Stocks #15696
Profound Medical Corp., along with its subsidiaries, operates as a... Profound Medical Corp., along with its subsidiaries, operates as a commercial-stage medical technology firm. The company specializes in creating magnetic resonance (MR) guided ablation therapies designed to address prostate conditions, uterine fibroids, and to provide palliative pain management. Its market reach extends to Canada, Germany, the United States, and Finland. The company's primary offering is the TULSA-PRO system, which is engineered to integrate with magnetic resonance imaging (MRI) scanners within hospitals and clinical treatment facilities. Additionally, Profound Medical offers Sonalleve, a versatile therapeutic platform that treats uterine fibroids, delivers palliative pain relief for bone metastases, and provides non-invasive solutions for uterine fibroid treatment. Profound Medical Corp. maintains its corporate headquarters in Mississauga, Canada.
Share Price
$6.38
Last synced: 2026-11-20
Market Cap
$235.45M
Change (1 day)
-3.19%
Change (1 year)
6.16%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Category

Healthcare
P/S ratio for Profound Medical Corp. (PROF)
P/S ratio as of November 2026 TTM: 11.54
According to Profound Medical Corp.'s latest financial reports and stock price, its current price-to-sales ratio (TTM) is 11.54. At the end of 2025 the company had a P/S ratio of 14.48.
P/S ratio history for Profound Medical Corp. from 2014 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
2026 (TTM) 11.54 -20.28%
2025 14.48 -42.21%
2024 25.05 -23.31%
2023 32.66 -27.46%
2022 45.03 6.05%
2021 42.46 -31.53%
2020 62.01 60.35%
2019 38.67 33.81%
2018 28.90 83.57%
2017 15.74 0.00%
2016 0.00 0.00%
2015 0.00 0.00%
2014 0.00 0.00%
P/S ratio for similar companies or competitors
Company P/S Ratio P/S Ratio Difference Country
3.90 -66.24%
US
3.50 -69.64%
IE
4.48 -61.17%
US
3.05 -73.58%
US
9.23 -20.04%
US

Questions about Profound Medical Corp.'s P/S ratio

What is Profound Medical Corp.'s P/S ratio?

Profound Medical Corp.'s P/S ratio is 11.54, as of Nov 2026.

What was Profound Medical Corp.'s P/S ratio in 2025?

In 2025, Profound Medical Corp.'s P/S ratio was 14.48, compared with 25.05 in 2024.

How has Profound Medical Corp.'s P/S ratio changed since 2020?

From 2020 to 2025, Profound Medical Corp.'s P/S ratio was highest in 2020 (62.01) and lowest in 2025 (14.48).

How does Profound Medical Corp.'s P/S ratio compare with similar companies?

Profound Medical Corp.'s P/S ratio (11.54) is higher than that of all 5 similar companies listed above. The highest among them is Edwards Lifesciences Corporation, with 9.23.